Curaleaf Holdings, Inc. CURA CURLF announced Thursday that it has launched a new edibles product, Select X Bites, which is
designed to have a faster onset, lasts longer and produces a stronger effect.
The formula features Select's award-winning oil and introduces proprietary encapsulation technology that mimics the body's natural lipid barrier, which optimizes the absorption of THC into the body at a steady, prolonged rate, resulting in a stronger and longer high.
Select X Bites, which debuted at the Hall of Flowers, will soon be available in Arizona, Maine, Colorado and Nevada with other states, including Massachusetts, Michigan, California, and Maryland, to follow early next year.
Each serving size of the new product will contain 10mg of THC. Initially, it will be available in a creamy vanilla-orange flavor called Orange Matter, with additional "out of this world" flavors debuting in the coming months.
"Over the past year, Select has introduced a number of new offerings that are not only satisfying unique consumer preferences but also pushing the envelope in terms of what is possible in cannabis, and we are exceptionally proud to introduce one of the most sophisticated edible products in the industry through Select X Bites," said Joe Bayern, the company's CEO. "Select was one of the early pioneers of nano-emulsion technology in cannabis which made edibles more predictable - now we are raising the bar and offering customers the opportunity to enjoy more potent edible experiences without compromising the speed or duration of the onset time."
Apart from the newly launched Select X Bites, the company's product portfolio also features Select Bites, Select Nano Bites and Select Snooze Bites.
More recent news from Curaleaf:
- Curaleaf And Fab 5 Freddy's B NOBLE To Launch In Cannabis Dispensaries In New York
- Curaleaf Opens 112th Dispensary & 9th In Arizona, Plans This Year's 'Cans For Kush' Food Drive
- Curaleaf Teams Up With Southern Glazer's Alcohol Beverage To Distribute Hemp & Select CBD Lines
CURLF Price Action
Curaleaf's shares traded 2.15% lower at $9.24 per share at the time of writing on Thursday morning.
Photo: Courtesy of Elsa Olofsson on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.